John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


Publication year:
All
21 - 30 out of 30Page size: 10
  1. 2017
  2. Published

    211th ENMC International Workshop: Development of diagnostic criteria and management strategies for McArdle Disease and related rare glycogenolytic disorders to improve standards of care. 17-19 April 2015, Naarden, The Netherlands

    Workshop Participants, W. P. & Vissing, John, 2017, In: Neuromuscular Disorders. 27, 12, p. 1143-1151

    Research output: Contribution to journal › Comment/debate › Research

  3. Published

    Leber hereditary optic neuropathy due to a new ND1 mutation

    Soldath, P., Wegener, Marianne, Sander, B., Rosenberg, T., Duno, M., Wibrand, F. & Vissing, John, 2017, In: Ophthalmic Genetics. 38, 5, p. 480-485 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Pure exercise intolerance and ophthalmoplegia associated with the m.12,294G > A mutation in the MT-TL2 gene: a case report

    Soldath, P., Madsen, K. L., Buch, A. E., Duno, M., Wibrand, F. & Vissing, John, Oct 2017, In: BMC Musculoskeletal Disorders. 18, 6 p., 419.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency

    Stemmerik, M. G., Madsen, K. L., Laforêt, P., Buch, A. E. & Vissing, John, 12 Dec 2017, In: Neurology. 89, 24, p. 2491-2494 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy

    Svenstrup, K., Nielsen, T. T., Aidt, F., Rostgaard, N., Duno, M., Wibrand, F., Vinther-Jensen, T., Law, Ian, Vissing, John, Roos, P., Hjermind, L. E. & Nielsen, Jørgen Erik, Feb 2017, In: The Cerebellum. 16, 1, p. 62-67 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Reply: Dominant LGMD2A: Alternative diagnosis or hidden digenism?

    Vissing, John & Duno, M., 2017, In: Brain. 140, 2, 2 p., e8.

    Research output: Contribution to journal › Comment/debate › Research

  8. Published

    PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose

    Voermans, N. C., Preisler, N., Madsen, K. L., Janssen, M. C. H., Kusters, B., Abu Bakar, N., Conte, F., Lamberti, V. M. L., Nusman, F., van Engelen, B. G., van Scherpenzeel, M., Vissing, John & Lefeber, D. J., 2017, In: Neuromuscular Disorders. 27, 4, p. 370-376

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

    Witting, N., Werlauff, U., Duno, M. & Vissing, John, Apr 2017, In: Neurology: Genetics. 3, 2, 15 p., e140.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience

    van der Ploeg, A. T., Kruijshaar, M. E., Toscano, A., Laforêt, P., Angelini, C., Lachmann, R. H., Pascual Pascual, S. I., Roberts, M., Rösler, K., Stulnig, T. M., van Doorn, P. A., Van den Bergh, P. Y. K., Vissing, John, Schoser, B. & European Pompe Consortium, E. P. C., Jun 2017, In: European Journal of Neurology. 24, 6, p. 768-e31

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Treatment Opportunities in Patients With Metabolic Myopathies

    Ørngreen, M. C. & Vissing, John, 2017, In: Current Treatment Options in Neurology. 19, 11, 16 p., 37.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 Next

ID: 915367